CVRX

CVRx, Inc. (CVRX)
Healthcare • Medical Devices • $3.05 • MCap: 81,256,864 🌐
https://www.barostim.com • CVRx, Inc., a commercial-stage medical device company, engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases in the United States, Germany, and internationally. The company offers Barostim, an implantable device that delivers electrical pulses to baroreceptors located in the wall of the carotid artery to counteract decreased baroreceptor signaling, and provides baroreflex activation therapy, which links the cardiovascular system to the autonomic nervous system. It sells its products through direct sales force, sales agents, and independent distributors. The company was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.
Buy Decision Core
Total Score
40
Business Quality
10
Financial Strength
8
Growth Outlook
1
Momentum
2
Price Action
Current
3.05
52W High
10.81
52W Low
2.37
Above 50DMA
4.30 (-29.00%)
Above 200DMA
6.51 (-53.15%)
Relative Strength
Relative Strength
-0.56
RS 3M
-0.43
RS 6M
-0.63
RS 9M
-0.67
RS 12M
-0.62
Fundamentals
Revenue Growth
0.16%
Earnings Growth
0%
ROE
-1.33%
ROA
-0.29%
Valuation
PE (Fwd)
-1.62
PEG
0
P/B
4.07
Upside
50.27%
Risk
Beta
0.76
Short %
0.12
Risk Score
9.00
Analyst
Rating
none
Target
4.58
Beta
0.76
Analysts
0


Total Score
40
Upside
50.27%
Relative Strength
-0.56
Beta
0.76
Why Buy?
  • PEG Ratio below 1 (attractive valuation)
  • Analyst upside exceeds 15%
Key Risks
  • Negative ROE
  • Weak long-term relative strength
Score Breakdown
Business
10
Financial
8
Growth
1
Valuation
12
Risk
3
Momentum
2
Technical
52W High: 10.81
52W Low: 2.37
Above 50DMA: -29.00%
Above 200DMA: -53.15%
Valuation
Forward PE: -1.62
PEG: 0
P/B: 4.07
Upside: 50.27%
Risk
Beta: 0.76
Short Float: 0.12%
ROE: -1.33%
ROA: -0.29%